| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |